In a statement issued on Monday, the Pfizer spokesperson said: “Pfizer’s discussions with the Indian government are ongoing and we hope to be able to use the Pfizer-BioNTech Covid-19 vaccine in the country. We are unable to to disclose more details at this time. ” In public tenders, the US vaccine maker said it would only supply vaccines to central governments.
Pfizer will only supply the Covid-19 vaccine to central governments and supranational organizations for deployment in national immunization programs. Dose allocation and implementation plan in a country is a decision of local governments on the basis of guidelines from relevant health authorities, “the statement said.
Pfizer said the development, manufacture, distribution and storage of complex innovative products, including mRNA technology, require optimized supply chains on a global scale.
“Since the start of this pandemic, Pfizer’s priority has been to ensure the rapid manufacture and deployment of the Covid-19 vaccine to respond to the current emergency response scenario. We have a strong supply chain currently in place with established capabilities – one in each country. The United States and one in Europe – who can quickly manufacture and deploy the vaccine for use around the world, “the spokesperson said.
Pfizer and BioNTech have set a goal of delivering more than 2.5 billion doses of vaccine by 2021. This includes expanding manufacturing capabilities and increasing the supplier base for key materials in the supply chain. procurement, the company official said.